Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Share Options and Director/PDMR Dealing

4 Aug 2022 07:00

RNS Number : 8451U
Quadrise Fuels International PLC
04 August 2022
 

4 August 2022

 

Quadrise Fuels International plc

("Quadrise", "QFI" or "the Company")

 

Issue of Share Options and Director/PDMR Dealing

 

Quadrise, the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, announces the grant of an aggregate of 32,882,979 options to subscribe for new ordinary shares of 1p each in the Company ("Ordinary Shares") to directors and employees of the Company in accordance with the provisions of the Company's Unapproved Share Option Plan 2016 ("2016 Plan") and the Company's Enterprise Management Incentive Share Option Plan ("EMI Plan"), as appropriate (the "Options").

 

Of the Options, a total of 12,500,000 performance share options (the "Performance Options") have been awarded to executives of the Company, including awards to certain of the Company's directors and PDMRs in the amounts set out below.

 

The award of Performance Options to Jason Miles, Quadrise's Chief Executive Officer, follows a prior share options award to Mr. Miles on 3 September 2021 which will lapse unvested on the first anniversary of their grant date due to their specific performance conditions not having been met.

 

Director/PDMR

Number of Options

Plan

Exercise price

Jason Miles

7,500,000

2016 Plan

3.0p

David Scott

1,250,000

EMI Plan

3.0p

Philip Hill

1,000,000

EMI Plan

3.0p

Total

9,750,000

-

-

 

The Performance Options will vest as to 50% on the first anniversary of grant and the remaining 50% shall vest on the second anniversary of the date of grant. All vestings are subject to the satisfaction of specific performance conditions prior to the vesting dates.

 

The Performance Options awarded under the 2016 Plan will be exercisable from vesting until the eighth anniversary of the date of grant and the Performance Options awarded under the EMI Plan will be exercisable from vesting until the tenth anniversary of the date of grant.

 

In addition to the Performance Options, the Company has also granted a total of 14,000,000 additional Options to Non-Executive Directors of the Company in accordance with the provisions of the 2016 Plan, in the amounts set out below (the "Additional Options").

 

Director

Number of Options

Plan

Exercise price

Andrew Morrison

4,000,000

2016 Plan

3.0p

Laurie Mutch

4,000,000

2016 Plan

3.0p

Philip Snaith

4,000,000

2016 Plan

3.0p

Dilip Shah

2,000,000

2016 Plan

3.0p

Total

14,000,000

-

-

 

The Additional Options will vest as to 50% on the first anniversary of grant and the remaining 50% shall vest on the second anniversary of the date of grant and have no performance conditions to vesting attached. The Additional Options will be exercisable from vesting until the eighth anniversary of the date of grant. The vestings are not subject to the satisfaction of specific performance conditions.

 

The Company also announces the issue a total of 6,382,979 nominal value options ("NVOs") to certain of the Company's PDMRs and employees in lieu of cash bonuses for the financial year ended 30 June 2022. The NVOs have been issued in accordance with and under the EMI Plan. The issue of NVOs include the following awards to certain of the Company's PDMRs:

 

PDMR

Number of NVOs

Plan

Exercise price

David Scott

1,914,894

EMI Plan

 

1.0p

Philip Hill

212,766

EMI Plan

1.0p

Total

2,127,660

-

-

 

The NVOs will vest after 12 months from the date of grant, have no performance conditions and will be exercisable from vesting until the tenth anniversary of the date of grant.

 

Following the grant of the Performance Options, the Additional Options and the NVOs, the Company has a total of 61,871,770 options to subscribe for new Ordinary Shares in the Company under option, representing approximately 4.40% of the Company's current issued ordinary share capital. In addition, the Company has a further 40,223,716 Ordinary Shares under warrant, representing 2.86% of the Company's current issued ordinary share capital.

 

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further details.

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

 

Quadrise Fuels International Plc

Jason Miles, Chief Executive Officer +44 (0)20 7031 7321

David Scott, Head of Finance

Nominated Adviser

Cenkos Securities plc

Ben Jeynes +44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs +44 (0)20 7408 4090

Fiona Conroy

 

Public & Investor Relations

Vigo Consulting

 Patrick D'Ancona +44 (0)20 7390 0230

Charlie Neish

 

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Jason Miles

2. David Scott

3. David Scott

4. Philip Hill

5. Philip Hill

6. Andrew Morrison

7. Laurie Mutch

8. Philip Snaith

9. Dilip Shah

 

 

2

Reason for notification

a)

Position/Status

1. Chief Executive Officer

2. Head of Finance

3. Head of Finance

4. Chief Operating Officer

5. Chief Operating Officer

6. Non-Executive Chairman

7. Non-Executive Director

8. Non-Executive Director

9. Non-Executive Director

 

 

Initial notification/amendment

Initial notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise Fuels International plc

 

 

b)

LEI

213800HN2ETG5476U328

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

 

b)

Nature of transaction

Awards of options to subscribe for new ordinary shares under the Quadrise Unapproved Share Option Plan 2016 and/or the Quadrise Enterprise Management Incentive Share Option Plan.

 

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

8. Nil

9. Nil

 

1. 7,500,000

2. 1,250,000

3. 1,914,894

4. 1,000,000

5. 212,766

6. 4,000,000

7. 4,000,000

8. 4,000,000

9. 2,000,000

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

3 August 2022

 

 

f)

Place of transaction

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUMGRUPPGMW
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSUpdate on active programmes
24th Feb 20147:00 amRNSRoyalty Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.